Return-Path: Received: from ensim.rackshack.net (root@localhost) by orafaq.net (8.11.6/8.11.6) with ESMTP id g9ALbFT27730 for ; Thu, 10 Oct 2002 16:37:15 -0500 X-ClientAddr: 209.68.248.164 Received: from newsfeed.cts.com (newsfeed.cts.com [209.68.248.164]) by ensim.rackshack.net (8.11.6/8.11.6) with ESMTP id g9ALbED27724 for ; Thu, 10 Oct 2002 16:37:14 -0500 Received: from fatcity.UUCP (uucp@localhost) by newsfeed.cts.com (8.9.3/8.9.3) with UUCP id MAA58477; Thu, 10 Oct 2002 12:18:20 -0700 (PDT) Received: by fatcity.com (26-Feb-2001/v1.0g-b72/bab) via UUCP id 004E623C; Thu, 10 Oct 2002 12:09:57 -0800 Message-ID: Date: Thu, 10 Oct 2002 12:09:57 -0800 To: Multiple recipients of list ORACLE-L X-Comment: Oracle RDBMS Community Forum X-Sender: Greg Moore Sender: root@fatcity.com Reply-To: ORACLE-L@fatcity.com Errors-To: ML-ERRORS@fatcity.com From: Greg Moore Subject: Re: bioinformatics Organization: Fat City Network Services, San Diego, California X-ListServer: v1.0g, build 72; ListGuru (c) 1996-2001 Bruce A. Bergman Precedence: bulk Mime-Version: 1.0 Content-type: text/plain; charset=iso-8859-1 Content-transfer-encoding: 7bit > is there any strategy from oracle in bioinformatics? Oracle has application software they call Oracle Clinical. Apparently it is designed to support clinical trials of new drugs. If you find out more on this topic I hope you'll post it to this list. -- Please see the official ORACLE-L FAQ: http://www.orafaq.com -- Author: Greg Moore INET: sqlgreg@pacbell.net Fat City Network Services -- 858-538-5051 http://www.fatcity.com San Diego, California -- Mailing list and web hosting services --------------------------------------------------------------------- To REMOVE yourself from this mailing list, send an E-Mail message to: ListGuru@fatcity.com (note EXACT spelling of 'ListGuru') and in the message BODY, include a line containing: UNSUB ORACLE-L (or the name of mailing list you want to be removed from). You may also send the HELP command for other information (like subscribing).